Medicine & Life Sciences
Prostatic Neoplasms
100%
Urinary Bladder Neoplasms
65%
Castration
56%
Residual Neoplasm
36%
Neoplasms
34%
Renal Cell Carcinoma
33%
abiraterone
29%
Survival
26%
Cystectomy
25%
MDV 3100
24%
Immunotherapy
23%
Proteogenomics
22%
Mutation
21%
Muscles
20%
Liquid Biopsy
18%
Circulating Tumor DNA
17%
pazopanib
17%
CSK Tyrosine-Protein Kinase
17%
Cohort Studies
16%
Neoplasm Metastasis
16%
Clinical Trials
16%
Urine
16%
Peritoneal Neoplasms
15%
Hospices
14%
DNA
14%
Radiotherapy
14%
Poly(ADP-ribose) Polymerase Inhibitors
13%
Prostatectomy
13%
Cyclin-Dependent Kinases
13%
Drug Therapy
13%
Therapeutics
12%
Recombinational DNA Repair
12%
Otitis Media
12%
Time-to-Treatment
12%
Chemoradiotherapy
12%
Pandemics
12%
Robotics
11%
Pulmonary Tuberculosis
11%
Veterans
11%
Medicare
11%
Gonadotropin-Releasing Hormone
11%
Zoledronic Acid
11%
Odds Ratio
11%
Crohn Disease
10%
Urinary Bladder
10%
Meals
10%
Epigenomics
10%
Carcinoma
9%
Prostate-Specific Antigen
9%
Tuberculosis
9%